Insider Transactions in Q1 2023 at Orthofix Medical Inc. (OFIX)
Insider Transaction List (Q1 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 10
2023
|
Shweta Maniar |
SELL
Open market or private sale
|
Direct |
4,262
-17.51%
|
$72,454
$17.75 P/Share
|
|
Feb 28
2023
|
Keith Valentine President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
16,290
-4.13%
|
$325,800
$20.6 P/Share
|
|
Feb 28
2023
|
John J. Bostjancic CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,783
-3.66%
|
$113,490
$30.6 P/Share
|
|
Feb 28
2023
|
Patrick L Keran Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,792
-4.3%
|
$75,840
$20.6 P/Share
|
|
Feb 01
2023
|
Kevin J. Kenny President of Global Spine |
SELL
Payment of exercise price or tax liability
|
Direct |
2,287
-1.57%
|
$48,027
$21.54 P/Share
|
|
Feb 01
2023
|
Jon Carl Serbousek Executive Chairman |
SELL
Payment of exercise price or tax liability
|
Direct |
5,142
-1.44%
|
$107,982
$21.54 P/Share
|
|
Feb 01
2023
|
Kimberley A. Elting President, Global Orthopedics |
SELL
Payment of exercise price or tax liability
|
Direct |
2,015
-1.09%
|
$42,315
$21.54 P/Share
|
|
Jan 30
2023
|
John J. Bostjancic CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,694
-1.61%
|
$35,574
$21.22 P/Share
|
|
Jan 30
2023
|
Keith Valentine President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
5,824
-1.46%
|
$122,304
$21.22 P/Share
|
|
Jan 30
2023
|
Patrick L Keran Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
999
-1.12%
|
$20,979
$21.22 P/Share
|
|
Jan 05
2023
|
Jon Carl Serbousek Executive Chairman |
BUY
Grant, award, or other acquisition
|
Direct |
337,206
+15.93%
|
-
|
|
Jan 05
2023
|
Kimberley A. Elting President, Global Orthopedics |
BUY
Grant, award, or other acquisition
|
Direct |
79,384
+10.97%
|
-
|
|
Jan 05
2023
|
Kevin J. Kenny President of Global Spine |
BUY
Grant, award, or other acquisition
|
Direct |
73,111
+13.09%
|
-
|
|
Jan 05
2023
|
Jason Hannon |
BUY
Grant, award, or other acquisition
|
Direct |
14,052
+30.99%
|
-
|
|
Jan 05
2023
|
Stuart Essig Director |
BUY
Grant, award, or other acquisition
|
Direct |
14,052
+6.4%
|
-
|
|
Jan 05
2023
|
John B Henneman Iii |
BUY
Grant, award, or other acquisition
|
Direct |
14,052
+22.48%
|
-
|
|
Jan 05
2023
|
Shweta Maniar |
BUY
Grant, award, or other acquisition
|
Direct |
14,052
+36.89%
|
-
|
|
Jan 05
2023
|
James F. Hinrichs Director |
BUY
Grant, award, or other acquisition
|
Direct |
14,052
+15.34%
|
-
|
|
Jan 05
2023
|
Keith Valentine President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
140,515
+26.0%
|
-
|
|
Jan 05
2023
|
Catherine M Burzik |
BUY
Grant, award, or other acquisition
|
Direct |
14,052
+30.02%
|
-
|
|
Jan 05
2023
|
John J. Bostjancic CFO |
BUY
Grant, award, or other acquisition
|
Direct |
35,128
+25.04%
|
-
|
|
Jan 05
2023
|
Patrick L Keran Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
35,128
+28.25%
|
-
|
|
Jan 05
2023
|
Michael E Paolucci |
BUY
Grant, award, or other acquisition
|
Direct |
14,052
+22.4%
|
-
|
|
Jan 03
2023
|
Kimberley A. Elting President, Global Orthopedics |
BUY
Grant, award, or other acquisition
|
Direct |
11,710
+9.97%
|
-
|